Current Oncology

Current Oncology is an international, peer-reviewed, open access journal published online by MDPI (from Volume 28 Issue 1-2021). The journal changes publication frequency from bimonthly to monthly in 2022. Established in 1994, the journal represents a multidisciplinary medium for clinical oncologists to report and review progress in the management of this disease. The Canadian Association of Medical Oncologists (CAMO), the Canadian Association of Psychosocial Oncology (CAPO), the Canadian Association of General Practitioners in Oncology (CAGPO) and Cell Therapy Transplant Canada (CTTC) are affiliated with the journal and their members receive a discount on the article processing charges.
  • Open Access— free to download, share, and reuse content. Authors receive recognition for their contribution when the paper is reused.
  • High Visibility: indexed within Scopus, SCIE (Web of Science), PubMed, MEDLINE, PMC, Embase, and many other databases.
  • Rapid Publication: manuscripts are peer-reviewed and a first decision provided to authors approximately 22 days after submission; acceptance to publication is undertaken in 3 days (median values for papers published in this journal in the second half of 2021).
  • Recognition of Reviewers: APC discount vouchers, optional signed peer review, and reviewer names published annually in the journal.
Impact Factor: 3.677 (2020) ; 5-Year Impact Factor: 3.089 (2020)
Add your e-mail address to receive forthcoming issues of this journal:
Topic in Biomolecules, Cancers, Cells, Current Oncology
Advances in Ovarian Cancer Research: From Biology to Therapeutics Editor-in-Chief: Christina M. Annunziata
Deadline: 31 May 2022
Topic in Biomolecules, Cancers, Cells, Current Oncology, Onco
Adaptation Mechanisms in Therapy-Resistant Breast Cancer Deadline: 31 July 2022
Topic in Biology, Cancers, Current Oncology, Diseases, IJERPH
The Role of Transmembrane Mucins in Lung Diseases Deadline: 31 October 2022
Topic in Biology, Biomolecules, Cancers, Current Oncology, Onco
Non Herbal Nutraceutical, Probiotic, Vitamins and Fatty Acids in Cancer Deadline: 15 November 2022
Special Issue in Current Oncology
Treatment of Recurrent High Grade Glioma Guest Editor: John Sinclair
Deadline: 31 January 2022
Special Issue in Current Oncology
Smoking Cessation after a Cancer Diagnosis Guest Editors: William K. Evans, Meredith Giuliani, Lawson Eng
Deadline: 15 February 2022
Special Issue in Current Oncology
Patient-Reported Outcome Use in Radiation Oncology Research and Routine Clinical Care Guest Editor: Robert Anton Olson
Deadline: 28 February 2022
Special Issue in Current Oncology
Advanced Care Planning in Oncology Guest Editor: Robin Urquhart
Deadline: 31 March 2022
Back to TopTop